BioCentury | Oct 13, 2017
Finance

Repurposing Recursion

With a $60 million series B round and a fourth pharma partnership, Recursion Pharmaceuticals Inc. plans to expand the use of its phenotypic screening platform to a broader range of chemical libraries and therapeutic areas....
BC Extra | Oct 10, 2017
Company News

Recursion, Takeda enter rare disease discovery partnership

Recursion Pharmaceuticals Inc. (Salt Lake City, Utah) and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) will collaborate to discover preclinical rare disease candidates for Takeda's TAK-celerator pipeline. Recursion will receive an undisclosed upfront payment and is eligible...
BC Week In Review | Oct 26, 2015
Financial News

Rheonix completes venture financing

Rheonix Inc. , Ithaca, N.Y.   Business: Diagnostic, Microfluidics   Date completed: 2015-10-20   Type: Venture financing   Raised: $28.6 million   Investors: Rand Capital Corp.; Cayuga Venture Fund; Advantage Capital Partners; Gefinor Capital; Limestone Capital...
BC Week In Review | Nov 12, 2012
Financial News

New Haven Pharmaceuticals completes venture financing

New Haven Pharmaceuticals Inc. , Guilford, Conn.   Business: Cardiovascular, Gastrointestinal   Date completed: 10/29/12   Type: Venture financing   Raised: $6.6 million   Investors: Connecticut Innovations; EJ Funds; Kuzari Group; Advantage Capital Partners; Yale University;...
BC Week In Review | Jun 13, 2011
Financial News

Esperance completes venture financing

Esperance Pharmaceuticals Inc. , Baton Rouge, La.   Business: Cancer   Date completed: 6/1/11   Type: Venture financing   Raised: Not disclosed   Investors: Sanofi ; Louisiana Fund; Themelios Ventures Partners; Research Corp. Technologies; Advantage Capital...
BC Extra | Jun 8, 2007
Financial News

Singulex raises $19.1 million

Singulex (Hayward, Calif.) raised $19.1 million in a series D round led by OrbiMed Advisors. Existing investors Fisk Ventures; Prolog Ventures; and Advantage Capital Partners also participated. Singulex is conducting pilot studies of its Erenna...
Items per page:
1 - 6 of 6
BioCentury | Oct 13, 2017
Finance

Repurposing Recursion

With a $60 million series B round and a fourth pharma partnership, Recursion Pharmaceuticals Inc. plans to expand the use of its phenotypic screening platform to a broader range of chemical libraries and therapeutic areas....
BC Extra | Oct 10, 2017
Company News

Recursion, Takeda enter rare disease discovery partnership

Recursion Pharmaceuticals Inc. (Salt Lake City, Utah) and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) will collaborate to discover preclinical rare disease candidates for Takeda's TAK-celerator pipeline. Recursion will receive an undisclosed upfront payment and is eligible...
BC Week In Review | Oct 26, 2015
Financial News

Rheonix completes venture financing

Rheonix Inc. , Ithaca, N.Y.   Business: Diagnostic, Microfluidics   Date completed: 2015-10-20   Type: Venture financing   Raised: $28.6 million   Investors: Rand Capital Corp.; Cayuga Venture Fund; Advantage Capital Partners; Gefinor Capital; Limestone Capital...
BC Week In Review | Nov 12, 2012
Financial News

New Haven Pharmaceuticals completes venture financing

New Haven Pharmaceuticals Inc. , Guilford, Conn.   Business: Cardiovascular, Gastrointestinal   Date completed: 10/29/12   Type: Venture financing   Raised: $6.6 million   Investors: Connecticut Innovations; EJ Funds; Kuzari Group; Advantage Capital Partners; Yale University;...
BC Week In Review | Jun 13, 2011
Financial News

Esperance completes venture financing

Esperance Pharmaceuticals Inc. , Baton Rouge, La.   Business: Cancer   Date completed: 6/1/11   Type: Venture financing   Raised: Not disclosed   Investors: Sanofi ; Louisiana Fund; Themelios Ventures Partners; Research Corp. Technologies; Advantage Capital...
BC Extra | Jun 8, 2007
Financial News

Singulex raises $19.1 million

Singulex (Hayward, Calif.) raised $19.1 million in a series D round led by OrbiMed Advisors. Existing investors Fisk Ventures; Prolog Ventures; and Advantage Capital Partners also participated. Singulex is conducting pilot studies of its Erenna...
Items per page:
1 - 6 of 6